Clinical trial
A Long-term Follow-up Study of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults
NCT03201211 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Long-term Follow-up Study of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 22, 2017
- Completion date
- March 19, 2020
- Enrollment
- 81 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
respiratory disorders